These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3966920)

  • 21. Mechanism for acivicin inactivation of triad glutamine amidotransferases.
    Chittur SV; Klem TJ; Shafer CM; Davisson VJ
    Biochemistry; 2001 Jan; 40(4):876-87. PubMed ID: 11170408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD; Sant ME; Christopherson RI
    J Biol Chem; 1990 Jul; 265(19):11377-81. PubMed ID: 2358467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
    Meck RA; Clubb KJ; Allen LM; Yunis AA
    Cancer Res; 1981 Nov; 41(11 Pt 1):4547-53. PubMed ID: 7306976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of inactivation of glutamine amidotransferases by the antitumor drug L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
    Tso JY; Bower SG; Zalkin H
    J Biol Chem; 1980 Jul; 255(14):6734-8. PubMed ID: 6993476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.
    McGovren JP; Pratt EA; Belt RJ; Taylor SA; Benjamin RS; Ardalan B; Ohnuma T
    Cancer Res; 1985 Sep; 45(9):4460-3. PubMed ID: 3896481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acivicin. An antitumor antibiotic.
    Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
    Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of acivicin and N-(phosphonacetyl)-L-aspartic acid in a biochemically designed trial against a N-(phosphonacetyl)-L-aspartic acid-resistant variant of the Lewis lung carcinoma.
    Kensler TW; Reck LJ; Cooney DA
    Cancer Res; 1981 Mar; 41(3):905-9. PubMed ID: 7459876
    [No Abstract]   [Full Text] [Related]  

  • 28. The glutamine hydrolysis function of human GMP synthetase. Identification of an essential active site cysteine.
    Nakamura J; Straub K; Wu J; Lou L
    J Biol Chem; 1995 Oct; 270(40):23450-5. PubMed ID: 7559506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of acivicin on glutamine transport by rat renal brush border membrane vesicles.
    Sastrasinh S; Sastrasinh M
    J Lab Clin Med; 1986 Oct; 108(4):301-8. PubMed ID: 2876045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purine enzymology of human colon carcinomas.
    Natsumeda Y; Lui MS; Emrani J; Faderan MA; Reardon MA; Eble JN; Glover JL; Weber G
    Cancer Res; 1985 Jun; 45(6):2556-9. PubMed ID: 3986794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutamine-dependent carbamoyl-phosphate synthetase and other enzyme activities related to the pyrimidine pathway in spleen of Squalus acanthias (spiny dogfish).
    Anderson PM
    Biochem J; 1989 Jul; 261(2):523-9. PubMed ID: 2570570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
    Allen L; Meck R; Yunis A
    Res Commun Chem Pathol Pharmacol; 1980 Jan; 27(1):175-82. PubMed ID: 6102405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acivicin: a highly active potential chemotherapeutic agent against visceral leishmaniasis.
    Mukherjee T; Roy K; Bhaduri A
    Biochem Biophys Res Commun; 1990 Jul; 170(2):426-32. PubMed ID: 2383250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.
    Jayaram HN; Cooney DA; Ryan JA; Neil G; Dion RL; Bono VH
    Cancer Chemother Rep; 1975; 59(3):481-91. PubMed ID: 1147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of insulin on liver carbamoyl-phosphate synthetase II (glutamine-hydrolyzing) activity.
    Reardon MA; Weber G
    Biochem Biophys Res Commun; 1983 Jul; 114(1):255-60. PubMed ID: 6349626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic carbamoyl phosphate metabolism. Role of cytosolic and mitochondrial carbamoyl phosphate in de novo pyrimidine synthesis.
    Pausch J; Rasenack J; Häussinger D; Gerok W
    Eur J Biochem; 1985 Jul; 150(1):189-94. PubMed ID: 4018077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme targets of antiglutamine agents in cancer chemotherapy.
    Prajda N
    Adv Enzyme Regul; 1985; 24():207-23. PubMed ID: 2424283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation and dephosphorylation of carbamoyl-phosphate synthetase II complex of rat ascites hepatoma cells.
    Otsuki T; Mori M; Tatibana M
    J Biochem; 1981 May; 89(5):1367-74. PubMed ID: 6115855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-(Phosphonacetyl)-L-aspartate inhibition of the enzyme complex of pyrimidine biosynthesis.
    Moore EC
    Biochem Pharmacol; 1982 Oct; 31(20):3313-6. PubMed ID: 7150357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.